CHICAGO, Jan. 04, 2018 -- Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months and full year ended December 31, 2017, after the close of stock market hours on Thursday, February 15, 2018. Allscripts management plans to host a conference call and webcast to discuss the company's earnings and other information at 4:30 p.m. Eastern Time that same day.
Fourth-Quarter 2017 Financial Results Call Details
The Allscripts earnings announcement will be distributed immediately after the close of regular stock market hours on February 15, 2018. The announcement will also be available at Allscripts investor relations website.
To listen to the conference call, participants may log onto the Allscripts Investor Relations website. Participants also may access the conference call by dialing (877) 269-7756 or 201-689-7817 (international) and requesting Conference ID # 13675041.
A replay of the call will be available approximately two hours after the conclusion of the call, for a period of four weeks, on the Allscripts investor relations website or by calling (877) 660-6853 or (201) 612-7415 - Conference ID # 13675041.
Allscripts to present at JP Morgan 36th Annual Healthcare Conference
Allscripts Chief Executive Officer Paul Black, President Rick Poulton and Chief Financial Officer Dennis Olis will present at the JP Morgan 36th Annual Healthcare Conference on January 9, 2018, at 2pm Pacific Time. The conference will be held in San Francisco, California, Jan. 8-11, 2018. More information is available here.
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
###
© 2018 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Danielle Protexter
312-386-6779
[email protected]
Media:
Concetta Rasiarmos
312-447-2466
[email protected]


Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
How Marco Pharma International Preserves German Homeopathic Traditions in America
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
FTC Questions Apple News Over Alleged Bias Against Conservative Media
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 



